Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 135, Issue 12, Pages 2834-2846
Publisher
Wiley
Online
2014-04-26
DOI
10.1002/ijc.28937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibodies Targeting Human OX40 Expand Effector T Cells and Block Inducible and Natural Regulatory T Cell Function
- (2013) K. S. Voo et al. JOURNAL OF IMMUNOLOGY
- Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment
- (2013) S. Rawal et al. JOURNAL OF IMMUNOLOGY
- Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial
- (2013) Jason R Westin et al. LANCET ONCOLOGY
- Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL
- (2011) P. Christopoulos et al. BLOOD
- T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
- (2011) B. E. Wahlin et al. CLINICAL CANCER RESEARCH
- Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
- (2011) Stephen J. Schuster et al. JOURNAL OF CLINICAL ONCOLOGY
- TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function
- (2011) M. H. Nyirenda et al. JOURNAL OF IMMUNOLOGY
- TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
- (2011) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells
- (2011) P Amé-Thomas et al. LEUKEMIA
- Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions
- (2011) Yeonseok Chung et al. NATURE MEDICINE
- TLR2-Dependent Induction of IL-10 and Foxp3+CD25+CD4+ Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo
- (2011) Sayuri Yamazaki et al. PLoS One
- Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma
- (2010) M. A. Navarrete et al. BLOOD
- Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice
- (2010) Qing Zhu et al. JOURNAL OF CLINICAL INVESTIGATION
- The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation
- (2009) P. Farinha et al. BLOOD
- Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
- (2009) R. Houot et al. BLOOD
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- The significance of OX40 and OX40L to T-cell biology and immune disease
- (2009) Michael Croft et al. IMMUNOLOGICAL REVIEWS
- OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
- (2009) Daniel Hirschhorn-Cymerman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Engagement of TLR2 Does not Reverse the Suppressor Function of Mouse Regulatory T Cells, but Promotes Their Survival
- (2009) Q. Chen et al. JOURNAL OF IMMUNOLOGY
- Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses
- (2009) Ye Zheng et al. NATURE
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
- (2009) Meghan A Koch et al. NATURE IMMUNOLOGY
- CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner
- (2009) A. Chaudhry et al. SCIENCE
- T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
- (2008) R. Houot et al. BLOOD
- Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma
- (2008) S. Mittal et al. BLOOD
- Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials
- (2008) Hyun Jun Park et al. BRITISH JOURNAL OF HAEMATOLOGY
- Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling
- (2008) Hirobumi Asai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- OX40 Agonist Therapy Enhances CD8 Infiltration and Decreases Immune Suppression in the Tumor
- (2008) M. J. Gough et al. CANCER RESEARCH
- Follicular lymphoma B cells induce the conversion of conventional CD4+T cells to T-regulatory cells
- (2008) Weiyun Z. Ai et al. INTERNATIONAL JOURNAL OF CANCER
- OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
- (2008) Silvia Piconese et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Toll-like receptors and immune regulation: implications for cancer therapy
- (2008) R-F Wang et al. ONCOGENE
- A novel strategy for rapid and efficient isolation of human tumor-specific CD4+ and CD8+ T-cell clones
- (2007) Seung-Tae Lee et al. JOURNAL OF IMMUNOLOGICAL METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started